What drugs does ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU make?

ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU has 1 FDA-approved drugs.

What therapeutic areas does ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU focus on?

ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU focuses primarily on Immunology and Oncology.

Data updated: Mar 10, 2026

ImmunologyOncology

Biotech

ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU is a biotechnology company focused on Immunology, Oncology.

2024

Since

Drugs

Trials

Approved (2yr)

No active drugs

SEC Filings ProEarly access

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 60%

0 drugs Phase 3: 2 Phase 2: 2

Oncology 40%

1 drugs Phase 1: 2